Manganese inhibits NMDA receptor channel function: Implications to psychiatric and cognitive effects

被引:59
作者
Guilarte, Tomas R. [1 ]
Chen, Ming-Kai [1 ]
机构
[1] Johns Hopkins Univ, Dept Environm Hlth Sci, Neurotoxicol & Mol Imaging Lab, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA
关键词
manganese; copper; NMDA receptor; H-3]-MK-801; rat brain; learning and memory;
D O I
10.1016/j.neuro.2007.06.005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Humans exposed to excess levels of manganese (Mn2+) express psychiatric problems and deficits in attention and learning and memory. However, there is a paucity of knowledge on molecular mechanisms by which Mn2+ produces such effects. We now report that Mn2+ is a potent inhibitor of [H-3]-MK-801 binding to the NMDA receptor channel in rat neuronal membrane preparations. The inhibition of [H-3]-MK-801 to the NMDA receptor channel by Mn2+ was activity-dependent since Mn2+ was a more potent inhibitor in the presence of the NMDA receptor coagonists glutarnate and glycine (K-i = 35.9 +/- 3.1 mu M) than in their absence (K-i = 157.1 +/- 6.5 mu M). We also show that Mn2+ is a NMDA receptor channel blocker since its inhibition of [H-3]-MK-801 binding to the NMDA receptor channel is competitive in nature. That is, Mn2+ significantly increased the affinity constant (K-d) with no significant effect on the maximal number of [H-3]-MK-801 binding sites (B-max). Under stimulating conditions, Mn2+ was equipotent in inhibiting [H-3]-MK-801 binding to NMDA receptors expressed in neuronal membrane preparations from different brain regions. However, under basal, non-stimulated conditions, Mn2+ was more potent in inhibiting NMDA receptors in the cerebellum than other brain regions. We have previously shown that chronic Mn2+ exposure in non-human primates increases Cu2+, but not zinc or iron concentrations in the basal ganglia [Guilarte TR, Chen M-K, McGlothan JL, Verina T, Wong DF, Zhou Y, Alexander M, Rohde CA, Syversen T, Decamp E, Koser AJ, Fritz S, Gonezi H, Anderson DW, Schneider JS. Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates. Exp Neurol 2006a;202:381-90]. Therefore, we also tested the inhibitory effects of Cu2+ on [H-3]-MK-801 binding to the NMDA receptor channel. The data shows that Cu2+ in the presence of glutarnate and glycine is a more potent inhibitor of the NMDA receptor than Mn2+. Our findings suggest that the inhibitory effect of Mn2+ and/or CU2+ on the NMDA receptor may produce a deficit in glutarnatergic transmission in the brain of individuals exposed to excess levels of Mn2+ and produce neurological dysfunction. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1147 / 1152
页数:6
相关论文
共 39 条
[11]  
Doreulee N, 1997, HIPPOCAMPUS, V7, P666, DOI 10.1002/(SICI)1098-1063(1997)7:6<666::AID-HIPO8>3.3.CO
[12]  
2-6
[13]   Tissue manganese concentrations in young male rhesus monkeys following subchronic manganese sulfate inhalation [J].
Dorman, David C. ;
Struve, Melanie F. ;
Marshall, Marianne W. ;
Parkinson, Carl U. ;
James, R. Arden ;
Wong, Brian A. .
TOXICOLOGICAL SCIENCES, 2006, 92 (01) :201-210
[14]   The physiological approach: Functional architecture of working memory and disordered cognition in schizophrenia [J].
Goldman-Rakic, PS .
BIOLOGICAL PSYCHIATRY, 1999, 46 (05) :650-661
[15]   Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure:: A 1H-MRS and MRI study [J].
Guilarte, Tomas R. ;
McGlothan, Jennifer L. ;
Degaonkar, Mahaveer ;
Chen, Ming-Kai ;
Barker, Peter B. ;
Syversen, Tore ;
Schneider, Jay S. .
TOXICOLOGICAL SCIENCES, 2006, 94 (02) :351-358
[16]   Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates [J].
Guilarte, Tomas R. ;
Chen, Ming-Kai ;
McGlothan, Jennifer L. ;
Verina, Tatyana ;
Wong, Dean F. ;
Zhou, Yun ;
Alexander, Mohab ;
Rohde, Charles A. ;
Syversen, Tore ;
Decamp, Emmanuel ;
Koser, Amy Jo ;
Fritz, Stephanie ;
Gonczi, Heather ;
Anderson, David W. ;
Schneider, Jay S. .
EXPERIMENTAL NEUROLOGY, 2006, 202 (02) :381-390
[17]  
GUILARTE TR, 1995, NEUROTOXICOLOGY, V16, P63
[18]  
Guilarte TR, 1997, NEUROTOXICOLOGY, V18, P665
[19]  
Hashemzadeh-Gargari H, 1999, J PHARMACOL EXP THER, V290, P1356
[20]   Neurologic manifestations in welders with pallidal MRI T1 hyperintensity [J].
Josephs, KA ;
Ahlskog, JE ;
Klos, KJ ;
Kumar, N ;
Fealey, RD ;
Trenerry, MR ;
Cowl, CT .
NEUROLOGY, 2005, 64 (12) :2033-2039